Interim Results on Sept. 25

Stem cell; cell based hair therapy
1

Here’s a cut and paste from REUTERS. I came across it while researching the stock.

Funny thing is, I actually called ICX this past Monday (Aug. 27–three days after this info was apparently released) to see if I could get an update on the status of Phase II. I was only told they expected to release results sometime in the second half of 2007.

REG-Intercytex Group plc Notice of Results

                                                                                                                   .

RNS Number:8028C
Intercytex Group plc
24 August 2007

Intercytex Group plc

                            Interims Results

24 August 2007 - Intercytex Group plc (LSE: ICX), the leading cell therapy
company focused on high impact treatments to restore and regenerate skin and
hair, today announces that it will report its interim results for the six months
ended 30 June 2007 on Tuesday 25 September 2007.

Enquiries:

Intercytex Group plc
Richard Moulson, Chief Financial Officer
Tel: 0161 904 4523

Financial Dynamics
Claire Rowell
Tel: 020 7831 3113

                  This information is provided by RNS 
        The company news service from the London Stock Exchange

END

2

Old news I put this on here last week - no one commented - I at least expected to be told by someone we know!

See link
http://www.hairsite.com/hair-loss/forum_entry.php?id=10323

Sorry ESP.I couldn’t help my self.All the best.

» Here’s a cut and paste from REUTERS. I came across it while researching
» the stock.
»
» Funny thing is, I actually called ICX this past Monday (Aug. 27–three
» days after this info was apparently released) to see if I could get an
» update on the status of Phase II. I was only told they expected to
» release results sometime in the second half of 2007.
»
»
»
» REG-Intercytex Group plc Notice of Results
»
»
» .
» RNS Number:8028C
» Intercytex Group plc
» 24 August 2007
»
» Intercytex Group plc
»
» Interims Results
»
» 24 August 2007 - Intercytex Group plc (LSE: ICX), the leading cell therapy
»
» company focused on high impact treatments to restore and regenerate skin
» and
» hair, today announces that it will report its interim results for the six
» months
» ended 30 June 2007 on Tuesday 25 September 2007.
»
» Enquiries:
»
» Intercytex Group plc
» Richard Moulson, Chief Financial Officer
» Tel: 0161 904 4523
»
» Financial Dynamics
» Claire Rowell
» Tel: 020 7831 3113
»
»
»
»
» This information is provided by RNS
» The company news service from the London Stock Exchange
» END

3

Sorry I missed it the first time you posted. You’re right though–I’d have thought we’d hear about it here first, instead of stumbling on it in a press article, and I’m surprised your post didn’t start a massive thread of speculation. Anyway, I’m beginning to wonder: what’s the point of subscribing to ICX’s email list for news updates…